Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection

Infection and Immunity

Volumn 69, Issue 11, 2001, Pages 6981-6986

  Watanabe, M ^a   Nagai, M ^a  

^a DAIICHI UNIVERSITY OF PHARMACY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FILAMENTOUS HEMAGGLUTININ; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; PERTACTIN; PERTACTIN ANTIBODY; PERTUSSIS TOXIN; TOXIN ANTIBODY; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE RELEASE; FEMALE; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SPLEEN CELL; TH1 CELL; TH2 CELL;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORDETELLA; BORDETELLA INFECTIONS; BORDETELLA PERTUSSIS; CONVALESCENCE; CROSS REACTIONS; DISEASE MODELS, ANIMAL; FEMALE; HEMAGGLUTININS; LUNG; MICE; PERTUSSIS TOXIN; RESPIRATORY TRACT INFECTIONS; SPLEEN; TIME FACTORS; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 0034783459     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.11.6981-6986.2001     Document Type: Article

References (32)

1. 3H]thymidine incorporation assay
2. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes
3. Interferon-gamma induction by lipopolysaccharide: Dependence on interleukin-2 and macrophages
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. Single-step purification of pertussis toxin and its subunits by heat-treated fetuin-sepharose affinity chromatography
6. Induction of a specific antibody response to Bordetella pertussis antigens in cultures of human peripheral blood mononuclear cells
7. Purification and analysis of the antigenicity of a 69,000 Da protein from Bordetella pertussis
8. Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin of Bordetella pertussis in Bordetella parapertussis infection
9. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection
10. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis
11. Mixed outbreak of Bordetella pertussis and Bordetella parapertussis in an apartment house
12. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice
13. Bordetella pertussis and Bordetella parapertussis: Two immunologically distinct species
14. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
15. Epidemics of parapertussis. 20 Years' observations in Denmark
16. Antibody response to pertussis toxin and filamentous haemagglutinin in NIH mice immunized with the International Standard for Pertussis Vaccine
17. Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin
18. Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland
19. Cell-mediated immunity to Bordetella pertussis: Role of Thl cells in bacterial clearance in a murine respiratory infection model
20. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis
21. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice
22. Pertussis today
23. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity
24. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: Differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells
25. Protection against experimental Bordetella bronchiseptica infection in mice by active immunization with killed vaccine
26. Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase
27. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine
28. The filamentous hemagglutinin of Bordetella parapertussis is the major adhesin in the phase-dependent interaction with NCI-H292 human lung epithelial cells
29. The host-parasite relationship in pertussis
30. Efficacy of pertussis vaccines consisted of antigens detoxified with tea-leaf catechins
31. Efficacy of chemically cross-linked antigens for acellular pertussis vaccine
32. The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model